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Proteins (enzymes, hormones, immunoglobulins, and numerous other types) account for
50% or more of the dry weight of most living systems and play a crucial role in virtually all
biological processes. Since the specific functions of essentially all biological molecules are
determined by their three-dimensional structures, it is obvious that a detailed understanding of
the structural makeup of a protein is essential to any systematic research pertaining to it. At the
present time, protein crystallography has no substitute: It is the only technique available for
elucidating the atomic arrangements within complicated biological molecules.
Most macromolecules are extremely difficult to crystallize, and many otherwise exciting
and promising projects have terminated at the crystal growth stage. Single crystals that have
dimensions of 0.2-1.0 mm on a side are generally required for x-ray crystallographic analyses of
macromolecular structures, and much larger crystals are required for neutron diffraction analyses.
Proteins and other biological macromolecules often yield small micro-crystals readily, but it
might then take several years of trial and error experimentation before these micro-crystals can
be induced to grow large enough for a complete structural analysis. Even when large crystals are
obtained, the crystals of essentially all biological macromolecules diffract rather poorly due to
internal disorder. Thus, there is a pressing need to better understand protein crystal growth, and
to develop new techniques that can be used to enhance the size and quality of protein crystals.
In principle, there are several aspects of microgravity that might be exploited to enhance
protein crystal growth. According to theoretical considerations and experiment results, the major
factor that might be expected to alter crystal growth processes in space is the elimination of
density-driven convective flow. Convection in solution growth is caused by density gradients
that occur when solute is depleted from the solution at the growing crystal surfaces. The
density-dependent convection might be expected to affect protein crystal growth from aqueous
solutions in several different ways. Convection will force solution to flow past the crystal, thus
bringing material to the growing crystal surfaces at a rate that is significantly different from the
steady-state diffusion rate that would be predominant in quiescent solutions. The flow patterns
may generate significant variation in concentration at different parts of a crystal, thus leading to
non-uniform growth rates. Also, convection may lead to significant physical stirring of growth
solutions; in general, it is expected that such stirring effects might alter nucleation in growth
processes.
Another factor that can be readily controlled in the absence of gravity is the
sedimentation of growing crystals in a gravitational field. When a protein crystal grows from
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aqueous solution on Earth, it generally migrates to the top or the bottom of the crystallization
vessel (depending on whether its density is greater or less than the density of the solution).
Therefore, protein crystals often grow from solution at an interface where all sides of the crystal
are not equally accessible to the crystallizing solution. (In most cases, sedimentation causes
proteins to crystallize as fused masses that contain highly disordered crystalline arrays.) Under
microgravity conditions, it is expected that protein crystals will not display this tendencey to
migrate away from initial nucleation sites, and can thus grow in isotonic environments, forming
discrete, independent nucleation in sites.
Another potential advantage of microgravity for protein crystal growth is the option of
doing containerless crystal growth. Contacts with vessel walls often lead to heterogeneous
nucleation in crystal growth solutions. In the microgravity environment, it may be possible to
form stable spherical droplets of crystallizing materials, which might be suspended by acoustical
levitation or other methods. It is definitely possible to form relatively large stable droplets of
protein solutions by extruding solutions from a pipette or a syringe; thus, protein crystals might
be grown under microgravity conditions in relative large droplets adhering to syringe tips,
without the extensive wall effects that generally accompany crystallization experiments on Earth.
As a result of the above theories and facts, one can readily understand why the
microgravity environment established by Earth-orbiting vehicles is perceived to offer unique
opportunities for the protein crystallographer. This perception led to the establishment of the
Protein Crystal Growth in a Microgravity Environment (PCG/ME) project that continues today
under NASA sponsorship. This project has advanced from simple hand-held devices (containing
only a few protein solutions) to a more complex system involving 60 or more individual protein
experiments in a thermally conditioned environment. The results of experiments already
performed during STS missions have in many cases resulted in protein crystals being growth that
are significantly larger and more structurally correct that the best specimens produced one earth.
Thusly, the near-term objective of the PCG/ME project is to continue to improve the techniques,
procedures, and hardware systems used to grow protein crystals in Earth orbit. A large number
of industrial guest investigators and co-investigators are involved in the project (reference
Attachment A) and multiple flight opportunities are obviously required to accomplish the
referenced objectives.
The hardware complement currently in use consists of a Refrigerator/Incubator Module
(R/IM) that provides protection and a controlled thermal environment (Figure 1), a Vapor
Diffusion Apparatus (VDA) designed to manipulate and process the protein samples (reference
Fig. 2). The VDA tray consists of 20 chamber assemblies, gang-operated dual cylinder syringes,
and gang-operated plug mechanisms. The overall assemly is mounted between two
aluminum/Plexiglas windows with a soft silicon rubber (35 to 65 durometer) gaskets providing
sealing of the overall assembly to prevent external leakage and chamber to chamber leakage.
The dual-cylinder syringe is made of polysulfone and is operated by a ganged piston
assembly. Each cylinder of the syringe contains a maximum of 40 Ixl of either precipitant or
protein solution. When the wheel that operates the ganged pistons is rotated, the solutions are
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either forced onto the syringe tip or withdrawn into the syringe cylinders, depending upon the
direction of the rotation. The drive assembly is designed such that from the launch configuration
of the syringe piston, eight to nine revolutions of the wheel are required to push solutions in the
cylinder to the tip of the syringe to form a drop. Several peripheral items of equipment such as a
temperature logging device and photographic equipment are also utilized. The current system
was first flown on STS-26 in September 1988, and was subsequently reflown on STS-29 in April
1989.
The STS-26 orbiter middeck experiment was the first temperature controlled or
systematic investigation to grow useful crystals by vapor diffusion in microgravity. Results from
this experiment were very encouraging, since high quality crystals were obtained from most of
the protein and enzyme samples flown and four samples grew crystals of exceptional size and
quality. The STS-29 results were not quite as promising as those from STS- 26 due to several
hardware/procedural problems. However, crystals of greater size and uniformity than those
grown on Earth were still produced. The knowledge gleaned from these flights is being applied
to follow-on PCG flights, in order to help define the flight and post-flight techniques and
analytical methods and procedures used.
The IML-1 mission will accommodate two R/IMs (4 °C and 22 °C). (Each R/IM replaces
one standard middeck locker, and uses Orbiter-provided 28 Vdc power from a standard outlet in
the ceiling of the middeck.) The samples being grown will utilize seeding crystals in the growth
process. The seeding crystal is inserted through a small opening in the top of the VDA window
using a drop dispenser. The drop dispensers are stowed in the R/IM during the mission. The
seed crystal is contained in a drop of stabilizing solution that is planted by allowing the
stabilizing solution drop to come into contact with the protein drop. The PCG experiment is
nominally activated during flight Day 1 activities. During activation, the PCG photo TV setup is
performed, the R/IM door is removed, and the solutions in the syringes are mixed by attaching a
handwheel to a syringe piston ganging mechanism and rotating it alternately clockwise and
counter-clockwise and then again clockwise to deploy the droplets from the tips of the syringes.
Once the droplets are deployed, the PCG photo session begins. During the photo sessions, a 35
mm camera is used to photograph the droplets on the tips of the syringes. The seed crystals are
planted 12 to 36 hours after activation. After completion of the seeding session the PCG unit is
left untouched until deactivation in the R/IM.
Disturbances during critical times such as activation plus 12 hours to activation plus 36
hours could cause premature nucleation. These disturbances could be caused by treadmill
activity or RCS firings. A showering effect results when crystal formation is disturbed, thus
resulting in many little crystals. These vibrational forces should be kept to a minimum for
maximum scientific results from the experiment.
PCG is deactivated on the last flight day prior to deorbit, at the latest possible time. The
deactivation process involves completing the final photo session, which is taking photographs of
the crystals formed on the tips of the syringes. Once the photo session is completed, the droplets
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areretractedbackinto thesyringes,the R/IM door is closed, and the PCG unit is ready to return
to the landing site.
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Figure 1. Refrigerator/Incubator Module (R/IM).
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